The left ovarian tumor, which had increased in size, exhibited fewer tumor-infiltrating CD4-positive and CD8-positive cells compared to the uterine tumor, suggesting different therapeutic responses between the two lesions (Fig. 2B). This evidence concerns the gene CD8A and tumor of uterus.